Additionally, we also analyzed the association between CRGs expression and pathological stage of BC patients by GEPIA2 tool, displaying stage-specific expressional changes of CDKN2A, LIPT1 and PDHA1 in BC patients (Figure 4). Here, CDKN2A is linked to breast cancer.